Vly News - Professional news Platform

As COVID numbers continue to rise, you may find yourself back at work at your kitchen table or home office. Key points: A study found people’s experiences of working from home were more negative than positive Respondents reported fatigue, blurred boundaries, and weight gain Researchers say the study reveals opportunities for employers to embark on effective work-from-home strategies There are benefits – travel is hard to beat, for one – but research from La Trobe University found most people have negative experiences when working from home. Those surveyed said the line between work and home life was blurred and they felt isolated from their peers. According to the lead researcher, Associate Professor Jodi Oakman, many respondents also reported fatigue and said their fitness was compromised. “When you go to work, you have a lot of incidental movement – you walk to a meeting, you walk to public transport, you get an extra step, whereas at home there is very little,” he says. But it’s not

Southampton [UK]July 10 (ANI): In the fight against Cancer, new insights into the key properties of antibodies have been discovered by researchers at the University of Southampton. The interdisciplinary study, published in Science Immunology, reveals how changing the flexibility of antibodies can stimulate a stronger immune response. Read Also | Guru Purnima 2022 Date and Time in India: Know Tithi, Its Customs and Importance of Celebrating the Birthday of the Great Vedic Saint Vyasa. These findings enabled the Southampton team to design antibodies to activate important receptors on immune cells to “turn them on” and provide a more potent anti-cancer effect. The scientists believe their findings could pave the way for improving antibody drugs that target cancer as well as other autoimmune diseases. Read Also | 2022 Wimbledon Final: Novak Djokovic Lifts 21st Grand Slam Title. In the study, the team investigated antibody drugs that target the CD40 receptor for cancer treatment. Clinica

Researchers at the University of Southampton have gained unprecedented new insights into the key properties of antibodies needed to fight cancer. The interdisciplinary study, published in Science Immunology, reveals how changing the flexibility of antibodies can stimulate a stronger immune response. These findings enabled the Southampton team to design antibodies to activate important receptors on immune cells to “turn them on” and provide a more potent anti-cancer effect. The scientists believe their findings could pave the way for improving antibody drugs that target cancer as well as other autoimmune diseases. In the study, the team investigated antibody drugs that target the CD40 receptor for cancer treatment. Clinical development is hampered by a lack of understanding of how to stimulate receptors to appropriate levels. The problem is that if the antibodies are overactive, they can become toxic. Previous Southampton studies have shown that a specific type of antibody called IgG2